Clinical Trial Update: Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function in Humans (HI-TECH) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating off-target effects of ticagrelor on endothelial function in humans (HI-TECH) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• BRILINTA (ticagrelor)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Cardiovascular Diseases | Phase 4 | Status: COMPLETED